Navigation Links
PrimeraDx Appoints David Heffelfinger as VP of Engineering and Systems Development
Date:12/1/2011

MANSFIELD, Mass., Dec. 1, 2011 /PRNewswire/ -- PrimeraDx today announced that David Heffelfinger has been appointed as Vice President of Engineering and Systems Development.

"It is an exciting time to join PrimeraDx.  The ICEPlex® System offers a glimpse into the future of molecular diagnostics, providing capabilities that are essential and timely," Commented Mr. Heffelfinger. 

"David brings to PrimeraDx extensive experience in the medical device industry and is a great addition to the executive team.  His knowledge and background in engineering and systems development, as well as his quality systems experience and six sigma training, are well aligned with the Company's strategy to provide next generation molecular diagnostics to the clinical laboratory market," said President and CEO Matthew McManus.

Mr. David Heffelfinger has held many Executive-level engineering positions within life science and medical device companies including Beckman Coulter, BD Biosciences, and Bio-Rad Laboratories as well as several startups and venture capital backed companies including Biometric Imaging, Alpha Innotech Corp, and Luminys Systems.  Dave was also a founder of his own company, Hyperspectra LLC.  He began his professional career at General Motors Research Laboratories in Warren, Michigan as an Applied Physicist.  He received his B.S. and M.S. in Physics from Wayne State University and an Executive MBA from Saint Mary's College in Moraga, California.  He holds 27 US and international patents in the fields of imaging, optics, bio-systems, and instrumentation.

About PrimeraDx

PrimeraDx is a molecular diagnostics company that has developed, and is commercializing, a novel, game-changing clinical platform which combines PCR with capillary electrophoresis.  The result of combining these two well-known technologies into a bench-top instrument is the ability to deliver highly multiplexed and quantitative, answers to the clinic.  The company is pursuing a two-pronged strategy to sell the system in an Open Platform Mode to clinical labs and to collaborate with pharmaceutical companies to develop high-value companion and enabling diagnostic products.  Users can easily design very complex multi-modal assays that test for disparate target types, like SNPs, expression biomarkers, microRNAs and fusion genes.  PrimeraDx's technology represents the next generation of quantitative PCR.  The Company is backed by a strong group of experienced venture-capital investors, including Abingworth, InterWest Partners, CHL Medical Partners, and Malaysia Technology Development Corporation.  The Company's website is: www.primeradx.com or www.multiplexpcr.com.

CONTACT: Andrew Bond, +1-508-618-2752, abond@primeradx.com


'/>"/>
SOURCE PrimeraDx
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PrimeraDx Launches the Only System Capable of Simultaneous Quantification of mRNA, microRNA and DNA
2. Ultragenyx Appoints Tom Kassberg as Chief Business Officer and Announces Management Team
3. CVS Caremark Appoints Kevin Murphy President of Accordant Business
4. Valeant Pharmaceuticals Appoints Howard B. Schiller as Chief Financial Officer
5. Adeona Appoints Jeff Lucero Riley as Independent Chairman
6. Champions Oncology, Inc. Appoints Executive Vice President and Chief Financial Officer to Management Team and Corporate Office Relocation
7. InterMune Appoints Angus C. Russell to Board of Directors
8. Volcano Corporation Appoints Leslie V. Norwalk and Dr. Eric J. Topol to Board of Directors
9. Vanda Pharmaceuticals Appoints Chief Commercial Officer
10. Cardica Appoints Christopher Littel VP, Sales and Marketing
11. S1 Pharmaceuticals Appoints Robert Taylor Segraves, MD, PhD, and Robert Pyke, MD, PhD to Its Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... OSWEGO, Ore. , Dec. 5, 2016   ... the BioInsight clinical study. The study evaluates the safety ... insertion procedure in an office setting. BioMonitor ... ® technology that is placed underneath a patient,s ... fibrillation and syncope (fainting). Atrial fibrillation is a leading ...
(Date:12/5/2016)... PITTSBURGH , Dec. 5, 2016  Wellbridge Health and ... innovative digital health solutions to Medicare and Medicaid plan members ... effort targeted at the unique needs of this group of ... on social work philosophies to provide insight into members, daily ... , ...
(Date:12/5/2016)... N.J. , Dec. 5, 2016  Daiichi ... preliminary safety and efficacy data from a phase ... MDM2 inhibitor, suggesting that DS-3032 may be a ... myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). ... the phase 1 study of DS-3032 were presented in ...
Breaking Medicine Technology:
(Date:12/4/2016)... ... December 03, 2016 , ... While James Earl Jones is known for myriad ... a show called "Front Page". One of the forthcoming episodes examines mammogram techniques; a ... plummeted in large part due to early detection. Like any other disease, treatments have ...
(Date:12/4/2016)... ... December 03, 2016 , ... Penrose Senior Care Auditors® was ... Tuesday evening at the 26th Annual SMU Cox Dallas 100™ Awards Ceremony and ... Institute for Entrepreneurship. Dallas 100™, co-founded by the Caruth Institute, honors the ingenuity, ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish ... take advantage of a cosmetic procedure known as Carbon Dioxide (C02) Fractional ... appearance of age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity ...
(Date:12/4/2016)... ... ... Responsible dental care hinges on regular brushing of the teeth. However, just brushing ... inspired an inventor from Las Vegas, Nev., to design the BRUSH PROPER. , ... bad techniques of brushing the teeth in order to prevent cavities," he said. "Children ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and ... will speak at the American Conference Institute’s 21st Drug & Medical Device Litigation ... Lead Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device ...
Breaking Medicine News(10 mins):